Bank of New York Mellon Corp Has $23.77 Million Holdings in Core Laboratories N.V. (CLB)
Bank of New York Mellon Corp lessened its holdings in Core Laboratories N.V. (NYSE:CLB) by 1.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 234,686 shares of the oil and gas company’s stock after selling 3,916 shares during the quarter. Bank of New York Mellon Corp owned 0.53% of Core Laboratories N.V. worth $23,766,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Parallel Advisors LLC increased its holdings in Core Laboratories N.V. by 33.4% in the 1st quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock valued at $101,000 after buying an additional 223 shares during the period. Quantbot Technologies LP bought a new stake in Core Laboratories N.V. in the 1st quarter valued at $106,000. FNY Managed Accounts LLC bought a new stake in Core Laboratories N.V. in the 1st quarter valued at $123,000. Shine Investment Advisory Services Inc. bought a new stake in Core Laboratories N.V. in the 2nd quarter valued at $134,000. Finally, First Bank & Trust increased its holdings in Core Laboratories N.V. by 5.8% in the 2nd quarter. First Bank & Trust now owns 1,493 shares of the oil and gas company’s stock valued at $152,000 after buying an additional 82 shares during the period.
ILLEGAL ACTIVITY WARNING: “Bank of New York Mellon Corp Has $23.77 Million Holdings in Core Laboratories N.V. (CLB)” was first published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/09/15/bank-of-new-york-mellon-corp-has-23-77-million-holdings-in-core-laboratories-n-v-clb.html.
Shares of Core Laboratories N.V. (NYSE:CLB) opened at 96.03 on Friday. The company has a market cap of $4.24 billion, a price-to-earnings ratio of 58.91 and a beta of 1.60. Core Laboratories N.V. has a 12-month low of $86.55 and a 12-month high of $125.83. The stock has a 50 day moving average of $93.20 and a 200 day moving average of $104.45.
Core Laboratories N.V. (NYSE:CLB) last posted its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 EPS for the quarter, beating the Zacks’ consensus estimate of $0.51 by $0.01. The business had revenue of $163.90 million during the quarter, compared to the consensus estimate of $168.23 million. Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. Core Laboratories N.V.’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.35 earnings per share. On average, equities analysts expect that Core Laboratories N.V. will post $2.00 earnings per share for the current fiscal year.
CLB has been the topic of several analyst reports. Zacks Investment Research raised shares of Core Laboratories N.V. from a “hold” rating to a “buy” rating and set a $116.00 price target on the stock in a report on Monday, June 12th. Royal Bank Of Canada set a $145.00 price target on shares of Core Laboratories N.V. and gave the company a “buy” rating in a report on Saturday, June 17th. BidaskClub raised shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Tuesday, June 13th. Piper Jaffray Companies set a $97.00 price target on shares of Core Laboratories N.V. and gave the company a “hold” rating in a report on Wednesday, July 26th. Finally, ValuEngine raised shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Friday, August 4th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company’s stock. Core Laboratories N.V. presently has an average rating of “Hold” and a consensus price target of $113.58.
About Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.